Melanin-concentrating hormone in peripheral circulation in the human. 2017

J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
Faculty of Science and TechnologyUniversity of Westminster, London, UK.

Melanin-concentrating hormone (MCH) is a hypothalamic neuropeptide with a well-characterised role in energy homeostasis and emergent roles in diverse physiologic functions such as arousal, mood and reproduction. Work to date has predominantly focused on its hypothalamic functions using animal models; however, little attention has been paid to its role in circulation in humans. The aims of this study were to (a) develop a radioimmunoassay for the detection of MCH in human plasma; (b) establish reference ranges for circulating MCH and (c) characterise the pattern of expression of circulating MCH in humans. A sensitive and specific RIA was developed and cross-validated by RP-HPLC and MS. The effective range was 19.5-1248 pg MCH/mL. Blood samples from 231 subjects were taken to establish a reference range of 19.5-55.4 pg/mL for fasting MCH concentrations. There were no significant differences between male and female fasting MCH concentrations; however, there were correlations between MCH concentrations and BMI in males and females with excess fat (P < 0.001 and P = 0.020) and between MCH concentrations and fat mass in females with excess fat (P = 0.038). Plasma MCH concentrations rose significantly after feeding in a group of older individuals (n = 50, males P = 0.006, females P = 0.023). There were no robust significant correlations between fasting or post-prandial MCH and resting metabolic rate, plasma glucose, insulin or leptin concentrations although there were correlations between circulating MCH and leptin concentrations in older individuals (P = 0.029). These results indicate that the role of circulating MCH may not be reflective of its regulatory hypothalamic role.

UI MeSH Term Description Entries
D007028 Hypothalamic Hormones Peptide hormones produced by NEURONS of various regions in the HYPOTHALAMUS. They are released into the pituitary portal circulation to stimulate or inhibit PITUITARY GLAND functions. VASOPRESSIN and OXYTOCIN, though produced in the hypothalamus, are not included here for they are transported down the AXONS to the POSTERIOR LOBE OF PITUITARY before being released into the portal circulation. Hypothalamic Pituitary-Regulating Hormones,Hypothalamic Pituitary-Regulating Peptides,Hormones, Hypothalamic,Hormones, Hypothalamic Pituitary-Regulating,Hypothalamic Pituitary Regulating Hormones,Hypothalamic Pituitary Regulating Peptides,Peptides, Hypothalamic Pituitary-Regulating,Pituitary-Regulating Hormones, Hypothalamic,Pituitary-Regulating Peptides, Hypothalamic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008543 Melanins Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. Allomelanins,Melanin,Phaeomelanins
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010907 Pituitary Hormones Hormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS. Hormones, Pituitary
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger

Related Publications

J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
January 1993, Peptides,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
May 1993, Annals of the New York Academy of Sciences,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
January 1989, Life sciences,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
May 1995, Neuroendocrinology,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
November 2009, Peptides,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
January 1989, Life sciences,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
April 1990, Molecular endocrinology (Baltimore, Md.),
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
November 2009, Peptides,
J Naufahu, and F Alzaid, and M Fiuza Brito, and B Doslikova, and T Valencia, and A Cunliffe, and J F Murray
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!